MEDICINE DETAILS
Repatha
Active ingredient: Evolocumab
Neutral reference profile for an independent medicine-access consultancy enquiry about Repatha (Evolocumab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Repatha used for?
Repatha (evolocumab) is a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody for lowering levels of fats in the blood. It is indicated to treat:
- Adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery.
- Adults with high blood cholesterol levels called primary hyperlipidemia (including heterozygous familial hypercholesterolemia [HeFH]) to reduce low density lipoprotein (LDL) or bad cholesterol. It is used along with diet alone or together with other cholesterol-lowering medicines.
- People with a type of high cholesterol called homozygous familial hypercholesterolemia (HoFH), who need additional lowering of LDL cholesterol. It is used along with other LDL-lowering medicines.
It is not known if this medicine is safe and effective in children with HoFH below 13 years of age or in children who do not have HoFH.
It is available as a solution for injection in pre-filled syringes (140 mg), pre-filled pens (140 mg), and cartridges (420 mg). The cartridges are used together with an automated dosing device called a mini-doser.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Repatha identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
140 mg · 2 pens Catalogue organisation: Amgen GmbH
-
140 mg solution for injection · 6 pens Catalogue organisation: BB FARMA S.R.L.
OFFICIAL SOURCES
Check the Repatha record at an official source.
Search for “Repatha” or “Evolocumab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Repatha.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Repatha
01What is Repatha?＋
This directory record associates the brand name Repatha with the active ingredient Evolocumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Repatha strengths and packs are recorded?＋
The catalogue currently shows: 140 mg · 2 pens; 140 mg solution for injection · 6 pens. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Repatha?＋
Catalogue records currently name: Amgen GmbH, BB FARMA S.R.L.. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Repatha?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Repatha, payment request, stock guarantee or binding offer.
06Can I buy Repatha from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.